s6y
Company name or ticker
Search
Lakewood-Amedex Biotherapeutics Inc.
424B3
Prospectus filed pursuant to Rule 424(b)(3)
Filed
Thursday, April 30, 2026
Accession number
0001213900-26-050264
Documents
PROSPECTUS SUPPLEMENT
424B3
On sec.gov
Filing index
All files
Complete submission text
SGML header